Item | Item no. | Yes | No | Partially | NA |
---|---|---|---|---|---|
Title and abstract | |||||
 Title | 1 | 17 | 1 | 1 | 0 |
 Abstract | 2 | 10 | 0 | 9 | 0 |
Introduction | |||||
 Background and objectives | 3a | 15 | 1 | 3 | 0 |
3b | 17 | 0 | 2 | 0 | |
Methods | |||||
 Target population and subgroups | 4 | 10 | 5 | 4 | 0 |
 Setting and location | 5 | 15 | 2 | 2 | 0 |
 Study perspective | 6 | 12 | 5 | 2 | 0 |
 Comparators | 7 | 12 | 1 | 6 | 0 |
 Time horizon | 8 | 10 | 6 | 3 | 0 |
 Discount rate | 9 | 7 | 5 | 3 | 4 |
 Choice of health outcomes | 10 | 10 | 0 | 9 | 0 |
 Measurement of effectiveness | 11a | 4 | 2 | 3 | 10 |
11b | 1 | 3 | 6 | 9 | |
 Measurement and valuation of preference based outcomes | 12 | 1 | 1 | 1 | 16 |
 Estimating resources and costs | 13a | 4 | 1 | 1 | 13 |
13b | 9 | 1 | 3 | 6 | |
 Currency, price date, and conversion | 14 | 11 | 5 | 3 | 0 |
 Choice of model | 15 | 6 | 4 | 3 | 6 |
 Assumptions | 16 | 11 | 2 | 0 | 6 |
 Analytical methods | 17 | 1 | 12 | 0 | 6 |
Results | |||||
 Study parameters | 18 | 15 | 2 | 2 | 0 |
 Incremental costs and outcomes | 19 | 13 | 3 | 3 | 0 |
 Characterising uncertainty | 20a | 3 | 0 | 1 | 15 |
20b | 13 | 0 | 2 | 4 | |
 Characterising heterogeneity | 21 | 8 | 5 | 1 | 5 |
Discussion | |||||
 Study findings, limitations, generalisability, and current knowledge | 22 | 12 | 0 | 7 | 0 |
Other | |||||
 Source of funding | 23 | 19 | 0 | 0 | 0 |
 Conflicts of interest | 24 | 10 | 9 | 0 | 0 |